Advertisements

Фенюльс

Quick links to important sections

Фенюльс

Selected form

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Фенюльс

Quick Facts

Attribute Detail
Classification Iron and Multivitamin Supplement
Active Ingredients Ferrous Sulfate, B-Complex Vitamins, Ascorbic Acid
Dosage Form Sustained-Release Capsule or Tablet
Availability Over-the-Counter (OTC) in many regions

Fenyuls (Фенюльс) is a specific brand-name pharmaceutical product widely used for the prevention and treatment of iron and associated nutritional deficiencies. It is formulated as a combination supplement, with its core components being an oral iron salt (typically Ferrous Sulfate) and a blend of B-complex vitamins, often including Folic Acid (B9), Thiamine (B1), and Cyanocobalamin (B12). The formulation usually also contains Ascorbic Acid (Vitamin C), which is included to help enhance the intestinal absorption of iron from supplements.

Fenyuls is particularly recognized for its sustained-release capsule technology. This method of delivery is designed to ensure a slow, gradual release of the iron throughout the digestive tract. This controlled delivery aims to minimize common gastrointestinal side effects—such as nausea, stomach upset, and constipation—that often accompany traditional high-dose oral iron supplements, thereby potentially improving patient adherence to treatment regimens.

This supplement is typically positioned as an accessible, over-the-counter option for individuals experiencing or at risk of iron-deficiency anemia, especially those with increased needs, such as pregnant or lactating women, adolescents, and individuals with chronic dietary restrictions. The combination of essential minerals and vitamins addresses the complex nature of many nutritional anemias, which frequently involve more than just an iron deficit.

Advertisements

What side effects are possible with Фенюльс?

Possible side effects and safety information

Official regulatory documentation structures the safety profile of this iron and multivitamin supplement primarily around the adverse reactions associated with the iron component.

Category Description (Regulatory-Aligned Factual Statement)
Key Adverse Reaction Categories Gastrointestinal disturbances are the primary category of non-serious adverse reactions.
Frequency Classification Common: Nausea, vomiting, abdominal pain, diarrhea, and constipation. Common/Expected: Black or dark stool discoloration. Uncommon to Rare: Hypersensitivity reactions, such as rash.
System-Organ Classes Gastrointestinal Disorders (most frequent); Immune System Disorders; Skin and Subcutaneous Tissue Disorders.
Serious Adverse Reactions Regulatory labels carry a mandatory warning regarding the risk of Acute Iron Poisoning, which is a leading cause of fatal poisoning in children under six years of age. Severe allergic reactions, including anaphylaxis, are documented as a rare risk.

Population-Specific Safety Considerations

The product is Contraindicated in individuals with pre-existing conditions that cause iron overload, such as hemochromatosis or hemosiderosis. Caution is advised in patients with active gastrointestinal conditions, including inflammatory bowel disease or ulcers. The mandatory safety constraint regarding the risk of fatal accidental overdose specifically targets the pediatric population.

Dose- or Exposure-Related Patterns

Adverse effects, particularly GI disturbances, are often documented as being more common at the start of treatment or during initial dose escalation. Furthermore, official labeling notes the high-level safety consequence of iron potentially interfering with the systemic absorption of certain other medications, such as some antibiotics and thyroid hormones.

Advertisements

Overdose and Emergency Response

The official regulatory description of Фенюльс overdose centers on the acute toxicity of its iron component, which is classified as severe and potentially life-threatening poisoning. Overdose symptoms typically begin with corrosive effects on the gastrointestinal tract, manifesting as severe abdominal pain, bloody vomiting, and diarrhea. This acute phase can rapidly progress to systemic collapse, marked by hypotension, tachycardia, lethargy, and the onset of metabolic acidosis or acute liver failure, culminating in seizures or shock.

A critical regulatory statement identifies accidental overdose of iron-containing products as a leading cause of fatal poisoning in children under six years of age, mandating that the product be kept strictly out of their reach.

Due to the risk of rapid systemic progression, regulatory guidance mandates seeking immediate medical attention for any suspected overdose, even if initial symptoms appear mild. Individuals with severe manifestations or high serum iron concentrations require hospitalization for continuous monitoring. Officially described management may include supportive measures, such as IV fluid resuscitation, gastrointestinal decontamination (e.g., Whole Bowel Irrigation), and the administration of the specific antidote, Deferoxamine, to chelate excess iron and prevent further systemic damage.

Advertisements

Therapeutic Uses of Фенюльс

What Фенюльс Treats: Main Uses and Benefits

The primary benefit of Fenyuls is its role as a combination supplement, applied across therapeutic domains where nutritional deficits create symptomatic burden. This supplement is considered relevant in contexts involving heightened systemic burden due to low iron, a component key for functional stability.

Fenyuls is commonly used to help with symptom clusters that interfere with daily comfort, such as persistent chronic fatigue, general weakness, and diminished physical stamina. It provides support for established Iron-Deficiency Anemia, latent iron deficiency, and combined nutritional shortfalls.

Core Therapeutic Support

The supplement provides support that helps address the underlying deficiency and assists with maintaining a sense of stability when symptoms are more noticeable. It is applied across conditions characterized by systemic imbalance resulting from insufficient iron stores. This includes nutritional assistance in high-demand scenarios, such as pregnancy, lactation, or periods of rapid growth.

“By supplying high-demand nutrients, the supplement may assist with preventing or managing deficiency and supports general well-being during symptomatic phases.”

Quick Fact: Relief for Chronic Fatigue This supplement may assist with easing the overall symptom load, contributes to easing discomfort, and supports day-to-day comfort for patients experiencing deficiency-related weakness and pallor.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Фенюльс (Fenyuls) — Official Regulatory Information

The eligibility profile for Фенюльс is strictly defined by regulatory documents, specifying populations who are allowed to use the medicine and those for whom it is contraindicated.

Eligibility Scope

Classification Populations and Conditions
Allowed Populations Adults and adolescents aged 12 years and older.
Contraindicated Populations Individuals with a documented hypersensitivity or allergy to any component of the preparation.
Condition-Specific Contraindications Patients diagnosed with iron overload disorders, specifically Hemochromatosis or Hemosiderosis.
Age-Related Rule The medicine is contraindicated for use in the pediatric population (children below the minimum eligible age of 12).

Pregnancy and Lactation Eligibility Status

Official labeling allows and indicates the use of Фенюльс for both pregnant women and lactating/breastfeeding women for the treatment and prevention of iron deficiency. This inclusion explicitly establishes eligibility during these physiological states.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Фенюльс, primarily an iron and B-vitamin complex, has a significant interaction profile chiefly due to the presence of ferrous sulfate. The main mechanism involves iron forming poorly soluble complexes (chelates) in the gastrointestinal tract, which reduces the absorption of both the iron and the co-administered medication.

Clinically Significant Drug Interactions

The following substances and drug classes are officially noted to interact, often requiring mandatory dosage spacing:

  • Antibiotics: Iron reduces the absorption of tetracyclines and fluoroquinolones. A time gap of at least 2 to 3 hours between doses is necessary to minimize this effect.
  • Thyroid Hormones: Absorption of levothyroxine is decreased by iron, necessitating separate administration times.
  • Biphosphonates: Iron interferes with the absorption of medications used for bone disorders, such as alendronate.
  • Antihypertensives and Parkinson's Drugs: The absorption of methyldopa, levodopa, and carbidopa may be reduced.
  • Antacids and Acid Reducers: Products containing aluminum, magnesium, or calcium, as well as acid-reducing drugs (H2 antagonists, PPIs), can decrease iron absorption.
  • Other Minerals: The absorption of both iron and zinc or calcium salts can be mutually reduced. High-dose ascorbic acid (Vitamin C) may increase iron absorption.

Food and Other Constraints

Consumption of certain foods, including dairy products, eggs, black tea, coffee, and high-fiber cereals, can inhibit the absorption of iron and should be separated from the product dose.

Advertisements

Mechanism of Action

The drug Fenyls acts through a multifaceted system to modulate key neurochemical pathways. Its effects are primarily focused on altering neuronal activity by enhancing inhibitory signals and modifying specific receptor domains.

Enhanced Serotonergic Neurotransmission

This domain covers the drug's effect on the serotonin (5-HT) system by acting within domains involving the serotonin transporter (SERT). Fenyls initiates a signaling cascade that increases the concentration of 5-HT in the synapse by inhibiting its reuptake and promoting its release. This increased functional availability of 5-HT in the synaptic cleft shifts the electrochemical gradient within targeted neural circuits.

Sigma-1 Receptor Modulation

This mechanistic domain involves the drug's activity as an agonist at the sigma-1 (sigma1) receptor. Engaging this mechanism modifies early molecular steps that influence the balance between excitatory (glutamatergic) and inhibitory ( GABAergic) neural networks. This modulation alters the balance between excitatory and inhibitory neurotransmission.

Advertisements

Dosage and Administration Information

The parameters for the use of Фенюльс (Ferrous Sulfate/Iron Supplement class) define the administration of this oral product.

Administration Scope

Route of administration Oral
Dosing schedule Typically 1 capsule once daily, or up to 2-3 times daily, depending on the elemental iron content and condition being addressed. Guidance may suggest once daily or on alternate days to maximize absorption.
Timing in relation to meals For optimal absorption, take at least 30 minutes before or 2 hours after a meal on an empty stomach. If gastrointestinal upset occurs, it may be taken with a small amount of food.
Age-group rules Adult strength is not for pediatric use. Pediatric dosing is based on the child's age and/or weight, and must be determined by a healthcare provider.
Missed-dose rules If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not take two doses at one time to make up for a missed dose.

Special Procedural Conditions

Administration Steps:

  • Swallow the modified-release capsule or tablet whole with a full glass of water or juice; do not crush, chew, or suck the tablet.
  • Do not take within two hours of consuming antacids, milk/dairy products, tea, coffee, or calcium supplements, as these can reduce iron absorption.
  • Continue treatment for the full prescribed duration (often 3 to 6 months) to fully replenish the body's iron stores.

This instruction map outlines the use of the medicine by establishing the oral route, the daily frequency, and the timing constraints (empty stomach/avoiding certain foods) required for the drug's sustained-release properties to function effectively. Adherence to these steps structures the patient protocol.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Phiенюльс

Evidence from Trials for Iron Deficiency Anemia (IDA)

Research has primarily was studied for the use of oral iron salts, the main component in Phiенюльс, in research exploring iron deficiency and iron deficiency anemia (IDA). These studies explored research examined the role of these supplements relative to key markers in the blood related to iron storage. The research base is comprised mainly of systematic reviews and randomized controlled trials (RCTs). In these research settings, studies monitored changes in blood tests, such as Hemoglobin (Hb) concentration and Serum Ferritin (a measure of iron stores).

Data show patterns related to changes in iron-related blood biomarkers when oral iron consumption was observed over defined time intervals. Research also was studied for outcomes related to physical discomfort, particularly symptoms like chronic fatigue and general weakness. While the role of oral iron in IDA was evaluated in numerous studies, comparative evidence is lacking to determine whether the specific combination formula (iron plus B-complex and Vitamin C) is associated with different measured patterns compared to iron alone.


Research on Combination Ingredients and Iron Absorption

Research was studied for the role of Ascorbic Acid (Vitamin C), a key ingredient in Phiенюльс, specifically in relation to iron intake. Studies have examined how Vitamin C, when taken alongside iron, may influence the absorption of iron through the digestive system and how this was studied for measured changes in the body’s iron levels.

Research examined how a combination approach may be relevant in conditions associated with systemic imbalance involving multiple nutritional shortfalls, which is why B-complex vitamins are included. However, comparative evidence is lacking from large-scale studies directly comparing the full Phiенюльс formulation to iron supplements without the complete range of B-vitamins.


Evaluation of the Sustained-Release Delivery System

Specific randomized controlled trials have evaluated in the sustained-release capsule format. These studies primarily focused on outcomes related to physical discomfort, such as the incidence and severity of gastrointestinal (GI) side effects often associated with immediate-release iron. Findings describe patterns observed in the studies where the sustained-release formats was observed in some studies to have different reported GI complaint rates, relative to immediate-release forms. Across the research, non-inferiority was assessed across the short study durations. The controlled-release may be associated with changes in blood markers comparable to those observed with immediate-release formulations.


Areas of Research Uncertainty and Gaps

Limited information for long-term outcomes is a key gap, as most trials focus only on initial correction, and follow-up durations were limited. Long-term effects are not fully established regarding the durability of the observed change. Furthermore, subgroup findings are uncertain in specific populations outside of pregnant women and adults with straightforward IDA. Research is ongoing regarding whether the specific B-vitamin profile in Phiенюльс is associated with different measured outcomes compared to standard iron/folic acid preparations.

Key Studies & References

  1. Daily iron and folic acid supplementation in pregnant women: Guideline
  2. Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Фенюльс (FAQ)


Q: Is Фенюльс a vitamin or a medication?

A: Official labeling generally classifies products containing iron (Ferrous Sulfate) and essential nutrients like B-Complex and Vitamin C as a Dietary Supplement or an Over-The-Counter (OTC) Drug. It is indicated for the prevention and treatment of nutritional deficiencies, meaning it addresses a specific health need, but it is not formally classified as a prescription medication.


Q: Why is Фенюльс sometimes prescribed for women?

A: The official product information indicates that the product is suitable for individuals with increased needs, particularly pregnant or lactating women. Women of childbearing age often require higher iron intake compared to men due to factors like menstrual blood loss. This is why official information notes them as a population with increased needs.


Q: Does Фенюльс help with fatigue or just iron levels?

A: Research studies have been conducted to monitor outcomes related to physical discomfort, such as chronic fatigue and general weakness, in individuals with iron deficiency anemia. Correcting the iron level in a deficiency state is observed in studies to be associated with improvements in related symptoms.


Q: What makes Фенюльс different from regular iron pills?

A: Фенюльс is recognized for its sustained-release capsule technology, which is designed to ensure a slow, gradual release of iron into the digestive tract. According to regulatory information, this controlled delivery aims to minimize common gastrointestinal side effects often associated with immediate-release iron, such as nausea and stomach upset.


Q: Are headaches a common side effect of Фенюльс?

A: Official drug information and safety profiles for iron supplements typically list gastrointestinal issues like nausea, constipation, diarrhea, and stomach pain as the common side effects. Headaches are generally not listed among the most frequent adverse reactions reported in the general regulatory documentation for oral iron.


Q: Do studies suggest Фенюльс is generally well-tolerated?

A: Official safety documents list specific adverse reactions, noting that the product’s sustained-release design aims to minimize gastrointestinal (GI) side effects. GI disturbances remain the primary category of non-serious adverse reactions. The sustained-release formulation is intended to minimize gastrointestinal side effects, which may support patient compliance with the treatment regimen.


Q: Are there any long-term effects associated with using Фенюльс?

A: Most clinical trials focus on correcting iron deficiency over a short-to-medium period (typically three to six months). Regulatory documents note that limited information is available for long-term outcomes and follow-up durations are limited. Long-term effects beyond the initial correction phase are not fully established, as most clinical trials conducted have limited follow-up durations.


Q: What is the purpose of the B-vitamins included in Фенюльс?

A: Фенюльс is a combination product that includes a blend of B-complex vitamins, such as B1, B9 (Folic Acid), and B12. This combination approach is relevant in conditions associated with systemic imbalance, as it addresses the complex nature of many nutritional deficiencies which may involve more than just an iron deficit.


Q: Are there specific warning signs associated with taking Фенюльс?

A: Regulatory documents carry a mandatory warning regarding the risk of Acute Iron Poisoning, which is a leading cause of fatal poisoning in young children. Severe adverse effects, such as signs of a serious overdose or an allergic reaction including breathing difficulty, are safety considerations that prompt contacting emergency services or a poison control center immediately.


Q: Can I take other supplements (like Vitamin D) with Фенюльс?

A: The absorption of iron can be mutually reduced by other minerals, specifically calcium and zinc. Official guidance indicates that combining supplements should be discussed with a healthcare provider to understand potential interactions and absorption dynamics.


Q: What is the maximum time a person is expected to use Фенюльс, according to regulatory information?

A: Treatment is typically continued for the full prescribed duration to fully replenish the body's iron stores, which is often cited as three to six months. Individual duration of use is generally guided by ongoing blood tests to ensure iron stores are fully replenished, rather than a universal regulatory maximum limit being defined.


Q: Is the absorption of iron from Фенюльс described as being reliable?

A: Official information describes the formulation as having a sustained-release format designed for gradual release. Furthermore, the inclusion of Ascorbic Acid (Vitamin C) is known to help enhance the intestinal absorption of iron from supplements. This aims to support proper iron intake and absorption according to the product's design.


Q: Do studies cover the effectiveness of Фенюльс in different patient groups?

A: Studies have explored the effectiveness of oral iron in populations like adults with iron deficiency anemia (IDA) and pregnant women. However, official research documents note that subgroup findings are uncertain in specific populations outside of these key groups, meaning more targeted research is not fully available.


Q: What is the difference between iron deficiency and anemia in the context of Фенюльс?

A: Regulatory documents state the product is indicated for the treatment of iron deficiency and anemia due to iron deficiency (IDA). Iron deficiency refers to low iron stores in the body. IDA is the more severe condition where the lack of iron has progressed to cause a reduction in red blood cell count or hemoglobin.


Q: What should I do if I accidentally take two capsules of Фенюльс?

A: Accidental overdose of iron-containing products is considered a serious risk, especially for young children. In the event of a suspected overdose, official safety guidance requires that emergency services or a national Poison Control Center be contacted immediately. This is a critical regulatory constraint due to the risk of iron poisoning.


Q: Why do official sources list specific contraindications for Фенюльс?

A: Official sources list contraindications like hemochromatosis or hemosiderosis because these conditions involve an existing overload of iron in the body. Regulatory documents indicate that using the product in these circumstances poses a risk of worsening iron overload, which is a serious safety concern.


Q: Is it normal for me to feel a metallic taste after taking Фенюльс?

A: Yes, official regulatory and clinical sources acknowledge that a metallic or coppery taste in the mouth is a documented and expected adverse effect of oral iron supplements. This taste is generally temporary and tends to subside as the supplement is absorbed.


Q: Can Фенюльс cause discoloration of the teeth?

A: Regulatory documentation for oral iron supplements lists teeth staining or discoloration as a possible side effect. This is more commonly associated with liquid iron drops or if tablets or capsules are chewed or held in the mouth, rather than when the capsule is swallowed whole.


Q: How is the safety of Фенюльс monitored by regulators?

A: The safety profile of the product is continuously evaluated through post-market surveillance. This process requires manufacturers and healthcare professionals to report serious and unexpected adverse events to regulatory bodies (like the FDA or EMA) so that the overall safety profile and official documents can be updated as needed.


Q: What is the significance of the specific dose of iron in Фенюльс?

A: The significance of the dose relates to its elemental iron content. The dose is formulated to provide an adequate amount of elemental iron to correct the nutritional deficiency, while the sustained-release mechanism is designed to minimize the gastrointestinal side effects often linked to higher iron doses.


Q: Are there any interactions with herbal supplements reported for Фенюльс?

A: Official guidance indicates that the combination of herbal remedies or supplements with ferrous sulfate should be discussed with a healthcare provider, due to the potential for other ingredients (like calcium or zinc) to interfere with iron absorption.

Advertisements

How should Фенюльс be stored and disposed of?

How to Store and Dispose of Фенюльс?

Store Фенюльс (Fenyuls) at room temperature, away from excess heat and moisture. Do not store it in the bathroom, as high humidity and temperature fluctuations can degrade the medication. Keep the medicine out of the reach of children and pets at all times to prevent accidental ingestion, particularly due to the presence of iron, which can be toxic in overdose.


  • Disposal: The preferred method for disposing of unused or expired medication is through a drug take-back program. Check with your local pharmacy or law enforcement for available programs in your area.
  • Home Disposal: If a take-back program is unavailable, you can dispose of Фенюльс in the household trash. First, mix the capsules with an unappealing substance like used coffee grounds, dirt, or cat litter. Place the mixture in a sealed bag or container to prevent leakage, and then discard it in your regular trash. Do not flush this medication down the toilet or pour it down a drain unless specifically instructed by the labeling or a healthcare professional, as this can contaminate the water supply.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Фенюльс found in:

A-Z Index: